China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 2,867 full-time employees. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.
China Shineway Pharmaceutical Group Limitedの主要な財務諸表は何ですか?
最新の財務諸表(Form-10K)によると、China Shineway Pharmaceutical Group Limitedの総資産は$10,041で、純利益は$840です。
CSWYYの主要な財務比率は何ですか?
China Shineway Pharmaceutical Group Limitedの流動比率は3.9、純利益率は22.23、1株当たり売上高は$5です。
China Shineway Pharmaceutical Group Limitedの収益はセグメントまたは地域別にどのように分けられていますか?
China Shineway Pharmaceutical Group Limited の最大収益セグメントは Injections で、最新の利益発表における収益は 1,374,777,459 です。地域別に見ると、China including Hong Kong が China Shineway Pharmaceutical Group Limited の主要市場であり、収益は 4,096,244,475 です。
China Shineway Pharmaceutical Group Limitedは収益を上げていますか?
はい、最新の財務諸表によると、China Shineway Pharmaceutical Group Limitedの純利益は$840です。
China Shineway Pharmaceutical Group Limitedに負債はありますか?
はい、China Shineway Pharmaceutical Group Limitedの負債は2,574です。
China Shineway Pharmaceutical Group Limitedの発行済株式数は何株ですか?
China Shineway Pharmaceutical Group Limitedの総発行済株式数は827株です。